1h Free Analyst Time
The global central nervous system (cns) stimulant drugs market is forecasted to grow by USD 9.54 billion during 2025-2030, accelerating at a CAGR of 7.0% during the forecast period. The report on the global central nervous system (cns) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of pediatric and adolescent diagnostic precision and evolution of early-intervention therapeutic protocols, expansion of adult neuro-performance demands and strategic rise of cognitive optimization in mature demographics, evolution of abuse-deterrent formulation science and strategic demand for cyber-secure and regulated distribution networks.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global central nervous system (cns) stimulant drugs market is segmented as below:
By Distribution Channel
- Hospitals
- Homecare
- Clinics
By Application
- Attention-deficit hyperactivity disorder
- Narcolepsy
- Others
By Route Of Administration
- Oral tablets and capsules
- Injectables
- Transdermal patches
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- The Netherlands
- Italy
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global central nervous system (cns) stimulant drugs market covers the following areas:
- Global central nervous system (cns) stimulant drugs market sizing
- Global central nervous system (cns) stimulant drugs market forecast
- Global central nervous system (cns) stimulant drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Central Nervous System (CNS) Stimulant Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI global central nervous system (CNS) stimulant drugs market
6.2 Impact of geopolitical conflict for global central nervous system (CNS) stimulant drugs market
6.2 Impact of geopolitical conflict for global central nervous system (CNS) stimulant drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- Chart on Homecare - Market size and forecast 2025-2030 ($ million)
- Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
- Chart on Homecare - Year-over-year growth 2025-2030 (%)
- Data Table on Homecare - Year-over-year growth 2025-2030 (%)
- Chart on Clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Clinics - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Application
9.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
- Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
- Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
- Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
- Chart on Narcolepsy - Market size and forecast 2025-2030 ($ million)
- Data Table on Narcolepsy - Market size and forecast 2025-2030 ($ million)
- Chart on Narcolepsy - Year-over-year growth 2025-2030 (%)
- Data Table on Narcolepsy - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
- Chart on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
- Data Table on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
- Chart on Injectables - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
- Chart on Injectables - Year-over-year growth 2025-2030 (%)
- Data Table on Injectables - Year-over-year growth 2025-2030 (%)
- Chart on Transdermal patches - Market size and forecast 2025-2030 ($ million)
- Data Table on Transdermal patches - Market size and forecast 2025-2030 ($ million)
- Chart on Transdermal patches - Year-over-year growth 2025-2030 (%)
- Data Table on Transdermal patches - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Integration of pediatric and adolescent diagnostic precision and evolution of early-intervention therapeutic protocols
- Expansion of adult neuro-performance demands and strategic rise of cognitive optimization in mature demographics
- Evolution of abuse-deterrent formulation science and strategic demand for cyber-secure and regulated distribution networks
- Intensification of regulatory oversight and structural constraints of prescription diversion control
- Persistence of global supply chain volatility and paradox of unmet patient demand
- Technical complexity of blood-brain barrier penetration and high failure rate of novel CNS innovation
- Impact of drivers and challenges in 2025 and 2030
- Institutionalization of specialized orexin agonists and shift toward non-monoaminergic wakefulness
- Growth of digital therapeutics and telepsychiatry-integrated monitoring systems
- Strategic transition toward abuse-deterrent formulations and controlled release harmonization
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Aytu BioPharma Inc. - Overview
- Aytu BioPharma Inc. - Product / Service
- Aytu BioPharma Inc. - Key offerings
- SWOT
- Azurity Pharmaceuticals Inc. - Overview
- Azurity Pharmaceuticals Inc. - Product / Service
- Azurity Pharmaceuticals Inc. - Key offerings
- SWOT
- Cosette Pharmaceuticals Inc. - Overview
- Cosette Pharmaceuticals Inc. - Product / Service
- Cosette Pharmaceuticals Inc. - Key offerings
- SWOT
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
- Lannett Co Inc. - Overview
- Lannett Co Inc. - Product / Service
- Lannett Co Inc. - Key offerings
- SWOT
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Noven Pharmaceuticals Inc. - Overview
- Noven Pharmaceuticals Inc. - Product / Service
- Noven Pharmaceuticals Inc. - Key offerings
- SWOT
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Purdue Pharma LP - Overview
- Purdue Pharma LP - Product / Service
- Purdue Pharma LP - Key offerings
- SWOT
- Supernus Pharmaceuticals Inc. - Overview
- Supernus Pharmaceuticals Inc. - Product / Service
- Supernus Pharmaceuticals Inc. - Key offerings
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Application - Market share 2025-2030 (%)
Exhibit 57: Data Table on Application - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
Exhibit 60: Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Narcolepsy - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Narcolepsy - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Narcolepsy - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Narcolepsy - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Application ($ million)
Exhibit 73: Data Table on Market opportunity by Application ($ million)
Exhibit 74: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 75: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Route of Administration
Exhibit 77: Data Table on Comparison by Route of Administration
Exhibit 78: Chart on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Transdermal patches - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Transdermal patches - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Transdermal patches - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Transdermal patches - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Route of Administration ($ million)
Exhibit 91: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: AbbVie Inc. - Overview
Exhibit 223: AbbVie Inc. - Business segments
Exhibit 224: AbbVie Inc. - Key offerings
Exhibit 225: AbbVie Inc. - Segment focus
Exhibit 226: SWOT
Exhibit 227: Aytu BioPharma Inc. - Overview
Exhibit 228: Aytu BioPharma Inc. - Product / Service
Exhibit 229: Aytu BioPharma Inc. - Key offerings
Exhibit 230: SWOT
Exhibit 231: Azurity Pharmaceuticals Inc. - Overview
Exhibit 232: Azurity Pharmaceuticals Inc. - Product / Service
Exhibit 233: Azurity Pharmaceuticals Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Cosette Pharmaceuticals Inc. - Overview
Exhibit 236: Cosette Pharmaceuticals Inc. - Product / Service
Exhibit 237: Cosette Pharmaceuticals Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Jazz Pharmaceuticals Plc - Overview
Exhibit 240: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 241: Jazz Pharmaceuticals Plc - Key offerings
Exhibit 242: SWOT
Exhibit 243: Lannett Co Inc. - Overview
Exhibit 244: Lannett Co Inc. - Product / Service
Exhibit 245: Lannett Co Inc. - Key offerings
Exhibit 246: SWOT
Exhibit 247: Mallinckrodt Plc - Overview
Exhibit 248: Mallinckrodt Plc - Business segments
Exhibit 249: Mallinckrodt Plc - Key offerings
Exhibit 250: Mallinckrodt Plc - Segment focus
Exhibit 251: SWOT
Exhibit 252: Novartis AG - Overview
Exhibit 253: Novartis AG - Business segments
Exhibit 254: Novartis AG - Key news
Exhibit 255: Novartis AG - Key offerings
Exhibit 256: Novartis AG - Segment focus
Exhibit 257: SWOT
Exhibit 258: Noven Pharmaceuticals Inc. - Overview
Exhibit 259: Noven Pharmaceuticals Inc. - Product / Service
Exhibit 260: Noven Pharmaceuticals Inc. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Otsuka Holdings Co. Ltd. - Overview
Exhibit 263: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 264: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 265: Otsuka Holdings Co. Ltd. - Segment focus
Exhibit 266: SWOT
Exhibit 267: Pfizer Inc. - Overview
Exhibit 268: Pfizer Inc. - Business segments
Exhibit 269: Pfizer Inc. - Key offerings
Exhibit 270: Pfizer Inc. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Purdue Pharma LP - Overview
Exhibit 273: Purdue Pharma LP - Product / Service
Exhibit 274: Purdue Pharma LP - Key offerings
Exhibit 275: SWOT
Exhibit 276: Supernus Pharmaceuticals Inc. - Overview
Exhibit 277: Supernus Pharmaceuticals Inc. - Product / Service
Exhibit 278: Supernus Pharmaceuticals Inc. - Key offerings
Exhibit 279: SWOT
Exhibit 280: Takeda Pharmaceutical Ltd. - Overview
Exhibit 281: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 282: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 283: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 284: SWOT
Exhibit 285: Teva Pharmaceutical Ltd. - Overview
Exhibit 286: Teva Pharmaceutical Ltd. - Business segments
Exhibit 287: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 288: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Inclusions checklist
Exhibit 291: Exclusions checklist
Exhibit 292: Currency conversion rates for US$
Exhibit 293: Research methodology
Exhibit 294: Information sources
Exhibit 295: Data validation
Exhibit 296: Validation techniques employed for market sizing
Exhibit 297: Data synthesis
Exhibit 298: 360 degree market analysis
Exhibit 299: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Application - Market share 2025-2030 (%)
Exhibit 57: Data Table on Application - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
Exhibit 60: Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Narcolepsy - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Narcolepsy - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Narcolepsy - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Narcolepsy - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Application ($ million)
Exhibit 73: Data Table on Market opportunity by Application ($ million)
Exhibit 74: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 75: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Route of Administration
Exhibit 77: Data Table on Comparison by Route of Administration
Exhibit 78: Chart on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Oral tablets and capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Oral tablets and capsules - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Transdermal patches - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Transdermal patches - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Transdermal patches - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Transdermal patches - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Route of Administration ($ million)
Exhibit 91: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: AbbVie Inc. - Overview
Exhibit 223: AbbVie Inc. - Business segments
Exhibit 224: AbbVie Inc. - Key offerings
Exhibit 225: AbbVie Inc. - Segment focus
Exhibit 226: SWOT
Exhibit 227: Aytu BioPharma Inc. - Overview
Exhibit 228: Aytu BioPharma Inc. - Product / Service
Exhibit 229: Aytu BioPharma Inc. - Key offerings
Exhibit 230: SWOT
Exhibit 231: Azurity Pharmaceuticals Inc. - Overview
Exhibit 232: Azurity Pharmaceuticals Inc. - Product / Service
Exhibit 233: Azurity Pharmaceuticals Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Cosette Pharmaceuticals Inc. - Overview
Exhibit 236: Cosette Pharmaceuticals Inc. - Product / Service
Exhibit 237: Cosette Pharmaceuticals Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Jazz Pharmaceuticals Plc - Overview
Exhibit 240: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 241: Jazz Pharmaceuticals Plc - Key offerings
Exhibit 242: SWOT
Exhibit 243: Lannett Co Inc. - Overview
Exhibit 244: Lannett Co Inc. - Product / Service
Exhibit 245: Lannett Co Inc. - Key offerings
Exhibit 246: SWOT
Exhibit 247: Mallinckrodt Plc - Overview
Exhibit 248: Mallinckrodt Plc - Business segments
Exhibit 249: Mallinckrodt Plc - Key offerings
Exhibit 250: Mallinckrodt Plc - Segment focus
Exhibit 251: SWOT
Exhibit 252: Novartis AG - Overview
Exhibit 253: Novartis AG - Business segments
Exhibit 254: Novartis AG - Key news
Exhibit 255: Novartis AG - Key offerings
Exhibit 256: Novartis AG - Segment focus
Exhibit 257: SWOT
Exhibit 258: Noven Pharmaceuticals Inc. - Overview
Exhibit 259: Noven Pharmaceuticals Inc. - Product / Service
Exhibit 260: Noven Pharmaceuticals Inc. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Otsuka Holdings Co. Ltd. - Overview
Exhibit 263: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 264: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 265: Otsuka Holdings Co. Ltd. - Segment focus
Exhibit 266: SWOT
Exhibit 267: Pfizer Inc. - Overview
Exhibit 268: Pfizer Inc. - Business segments
Exhibit 269: Pfizer Inc. - Key offerings
Exhibit 270: Pfizer Inc. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Purdue Pharma LP - Overview
Exhibit 273: Purdue Pharma LP - Product / Service
Exhibit 274: Purdue Pharma LP - Key offerings
Exhibit 275: SWOT
Exhibit 276: Supernus Pharmaceuticals Inc. - Overview
Exhibit 277: Supernus Pharmaceuticals Inc. - Product / Service
Exhibit 278: Supernus Pharmaceuticals Inc. - Key offerings
Exhibit 279: SWOT
Exhibit 280: Takeda Pharmaceutical Ltd. - Overview
Exhibit 281: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 282: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 283: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 284: SWOT
Exhibit 285: Teva Pharmaceutical Ltd. - Overview
Exhibit 286: Teva Pharmaceutical Ltd. - Business segments
Exhibit 287: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 288: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Inclusions checklist
Exhibit 291: Exclusions checklist
Exhibit 292: Currency conversion rates for US$
Exhibit 293: Research methodology
Exhibit 294: Information sources
Exhibit 295: Data validation
Exhibit 296: Validation techniques employed for market sizing
Exhibit 297: Data synthesis
Exhibit 298: 360 degree market analysis
Exhibit 299: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global central nervous system (cns) stimulant drugs market: AbbVie Inc., Amneal Pharmaceuticals Inc., Assertio Holdings Inc, Aytu BioPharma Inc., Azurity Pharmaceuticals Inc., Cosette Pharmaceuticals Inc., Jazz Pharmaceuticals Plc, Lannett Co Inc., Mallinckrodt Plc, Novartis AG, Noven Pharmaceuticals Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Rhodes Pharmaceuticals L.P., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Zealand Pharma.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is institutionalization of specialized orexin agonists and shift toward non-monoaminergic wakefulness."
According to the report, one of the major drivers for this market is the integration of pediatric and adolescent diagnostic precision and evolution of early-intervention therapeutic protocols.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amneal Pharmaceuticals Inc.
- Assertio Holdings Inc
- Aytu BioPharma Inc.
- Azurity Pharmaceuticals Inc.
- Cosette Pharmaceuticals Inc.
- Jazz Pharmaceuticals Plc
- Lannett Co Inc.
- Mallinckrodt Plc
- Novartis AG
- Noven Pharmaceuticals Inc.
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Purdue Pharma LP
- Rhodes Pharmaceuticals L.P.
- Supernus Pharmaceuticals Inc.
- Takeda Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd.
- Zealand Pharma
